🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT07300969
Recruiting Phase 2

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

NCT07300969 · tracked via the Priya Life Science UK tracker
Sponsor
Draig Therapeutics Ltd
Phase
Phase 2
Started
2025-12-16
Last updated
2026-08-26

Condition(s) studied

Major Depressive Disorder (MDD)

Investigational drug(s) / intervention(s)

DT-101DT-101Placebo

DT-101: DT-101 A

DT-101: DT-101 B

Placebo: Placebo

Study summary

The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * The participant is able to read, understand and communicate in the local language used at the study site, and is willing to provide written informed consent * Male or female (assigned at birth, inclusive of all gender identities) participant must be 18 to 75 years of age, inclusive at the time of signing the informed consent. * Has recurrent depression (defined as at least one prior episode excluding the current one), as diagnosed by DSM 5-TR (Diagnostic and Statistical Manual of Mental Disorders, 2022). Exclusion Criteria: * Pregnant or breastfeeding or plans to become pregnant during the study. * Unstable medical condition or unstable chronic disease. * Significant neurological abnormality. * History of moderate or severe alcohol or drug use disorder as per DSM-5-TR in the 6 months prior to Screening. * History of seizure. * In the investigator's opinion, the participant is not capable of adhering to the protocol requirements.

Primary outcome measure(s)

Trial sites (43)

FacilityCityRegionStatus
Draig Clinical Site Bentonville Arkansas Recruiting
Draig Clinical Site Little Rock Arkansas Recruiting
Draig Clinical Site Oceanside California Recruiting
Draig Clinical Site San Diego California Recruiting
Draig Clinical Site Torrance California Recruiting
Draig Clinical Site Miami Florida Recruiting
Draig Clinical Site New Port Richey Florida Recruiting
Draig Clinical Site Orlando Florida Recruiting
Draig Clinical Site Atlanta Georgia Recruiting
Draig Clinical Site Decatur Georgia Recruiting
Draig Clinical Site Gaithersburg Maryland Recruiting
Draig Clinical Site Watertown Massachusetts Recruiting
Draig Clinical Site Flowood Mississippi Recruiting
Draig Clinical Site Las Vegas Nevada Recruiting
Draig Clinical Site Marlton New Jersey Recruiting
Draig Clinical Site New York New York Recruiting
Draig Clinical Site Media Pennsylvania Recruiting
Draig Clinical Site Austin Texas Recruiting
Draig Clinical Site Austin Texas Recruiting
Draig Clinical Site DeSoto Texas Recruiting
Draig Clinical Site Richardson Texas Recruiting
Draig Clinical Site Wichita Falls Texas Recruiting
Draig Clinical Site Bellevue Washington Recruiting
Draig Clinical Site Kazanlak Bulgaria Recruiting
Draig Clinical Site Plovdiv Bulgaria Recruiting
Draig Clinical Site Sofia Bulgaria Recruiting
Draig Clinical Site Sofia Bulgaria Recruiting
Draig Clinical Site Sofia Bulgaria Recruiting
Draig Clinical Site Sofia Bulgaria Recruiting
Draig Clinical Site Vratsa Bulgaria Recruiting
Draig Clinical Site Ostrava Czechia Recruiting
Draig Clinical Site Prague Czechia Recruiting
Draig Clinical Site Říčany Czechia Recruiting
Draig Clinical Site Gdansk Poland Recruiting
Draig Clinical Site Katowice Poland Recruiting
Draig Clinical Site Poznan Poland Recruiting
Draig Clinical Site Chester United Kingdom Recruiting
Draig Clinical Site Eastbourne United Kingdom Recruiting
Draig Clinical Site Glasgow United Kingdom Recruiting
Draig Clinical Site London United Kingdom Recruiting

+ 3 more sites — see the full list on the official registry below.

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07300969 on ClinicalTrials.gov ↗ ← All trials in the UK